Intratumoral heterogeneity and genetic characteristics of prostate cancer-Reference-Cited by-同舟云学术

Intratumoral heterogeneity and genetic characteristics of prostate cancer

Published:2020-03-25 Issue:12 Volume:146 Page:3369-3378
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Wu Bo¹²,Lu Xin³,Shen Haibo⁴,Yuan Xiaobin¹,Wang Xin²,Yin Nan¹,Sun Libin²,Shen Pengliang¹,Hu Caoyang¹,Jiang Huanrong⁵,Wang Dongwen²⁵^ORCID

Affiliation:

1. Department of Urology First Hospital of Shanxi Medical University Taiyuan Shanxi China

2. First College of Clinical Medicine Shanxi Medical University Taiyuan Shanxi China

3. Department of Urology, Changhai Hospital Second Military Medical University Shanghai China

4. Department of Urology Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine Shanghai China

5. National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Shenzhen China

Funder

Shanxi Provincial Key Research and Development Project

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32961

Reference35 articles.

1. HISTOLOGICAL GRADE HETEROGENEITY IN MULTIFOCAL PROSTATE CANCER. BIOLOGICAL AND CLINICAL IMPLICATIONS

2. Cancer-Specific Mortality After Surgery or Radiation for Patients With Clinically Localized Prostate Cancer Managed During the Prostate-Specific Antigen Era

3. Validating the Interval to Biochemical Failure for the Identification of Potentially Lethal Prostate Cancer

4. Tumour heterogeneity poses a significant challenge to cancer biomarker research

5. Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-existing cell subpopulations in primary prostate cancer tumors display surface fingerprints of docetaxel-resistant cells;Cellular Oncology;2024-08-20

2. Emerging Perspectives in Zinc Transporter Research in Prostate Cancer: An Updated Review;Nutrients;2024-06-26

3. Multi-omics approach for identifying CNV-associated lncRNA signatures with prognostic value in prostate cancer;Non-coding RNA Research;2024-03

4. Heterogeneity of computational pathomic signature predicts drug resistance and intra-tumor heterogeneity of ovarian cancer;Translational Oncology;2024-02

5. A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3;npj Precision Oncology;2024-01-16